Register entry

Alexion Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
3
Active NDC listings
10
Labeller names
2
Live patents
4
Exclusivities
1
Countries
2
Base
Ireland
Authorisation

Registered operations

Analytical testing3Active ingredient (API) manufacture2Labelling1Finished drug manufacture2Packaging1
Sites

Registered establishments

3
EstablishmentAddressRegistered forFEI / DUNS
Alexion Pharma International Operations LimitedRegistrant: Alexion Pharmaceuticals, Inc.Monksland Industrial Estate, Athlone, N37 DH79, Ireland (IRL)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3011532960986018601
Alexion Pharma International Operations LimitedRegistrant: Alexion Pharmaceuticals, Inc.College Business and Technology Park, Dublin, D15 R925, Ireland (IRL)Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging3012889718985573659
Alexion Pharmaceuticals Inc.Registrant: Alexion Pharmaceuticals, Inc.1074 Gateway East Pkwy, Bogart, Georgia (GA) 30622-2007, United States (USA)Analytical testing, Finished drug manufacture3011263308079580471
Catalogue

Drug listings by form and route

10

10 active NDC listings: 10 human prescription drug. By marketing category: BLA 8, NDA 2.

Dosage formNDCs
solution4
solution, concentrate3
injection, solution, concentrate1
kit1
tablet, film coated1
RouteNDCs
intravenous4
subcutaneous4
oral1
Labeller name on the listingNDCs
alexion pharmaceuticals inc.6
alexion pharmaceuticals, inc.4
Exclusivity

Patents and exclusivities

4
PatentProductCoversExpiry
9796741VOYDEYAdanicopansubstanceFeb 2035
12076319VOYDEYAdanicopanuseAug 2038
ProductExclusivityUntil
VOYDEYADANICOPANODE-476 Orphan drugMar 2031
Catalogue

Marketed products

10
BrandGeneric nameForm / routeNDC
SOLIRISECULIZUMABinjection, solution, concentrate, intravenous25682-001BLA
STRENSIQASFOTASE ALFAsolution, subcutaneous25682-010BLA
STRENSIQASFOTASE ALFAsolution, subcutaneous25682-013BLA
STRENSIQASFOTASE ALFAsolution, subcutaneous25682-016BLA
STRENSIQASFOTASE ALFAsolution, subcutaneous25682-019BLA
Ultomirisravulizumabsolution, concentrate, intravenous25682-022BLA
Ultomirisravulizumabsolution, concentrate, intravenous25682-025BLA
Ultomirisravulizumabsolution, concentrate, intravenous25682-028BLA
VoydeyaDanicopantablet, film coated, oral25682-043NDA
VoydeyaDanicopankit25682-046NDA
Neighbours

Registered in the same town

12
Compare

Comparable companies in Ireland

Enquiry

Common questions

Is Alexion Pharmaceuticals, Inc. FDA approved?
Alexion Pharmaceuticals, Inc. holds 3 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Alexion Pharmaceuticals, Inc.'s drugs manufactured?
At registered sites in Ireland, the United States. The FDA register lists Athlone; Dublin; Bogart, GA. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does Alexion Pharmaceuticals, Inc. make?
10 products are listed under Alexion Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as solution; solution, concentrate; injection, solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.